Who gets cirrhosis of the liver? You might be surprised.
A new Ontario study has found cirrhosis rates are increasing the fastest among young adults. An epidemic of fatty liver disease is being pointed to as one possible cause for the spike.
Once considered a disease of older men, the face of cirrhosis of the liver is changing, say the authors of the study published in the journal The Lancet Gastroenterology and Hepatology on Thursday.
New cases of
Study could inform hepatitis C treatment and vaccine development worldwide
The largest population study of hepatitis C in Africa has found three new strains of the virus circulating in the general population in sub-Saharan Africa. The research from the Wellcome Sanger Institute, the MRC-University of Glasgow Centre for Virus Research and collaborators suggested that certain antiviral drugs currently used in the West may not be as effective against the new
Friday, Nov 23, 2018
News Recap:
Links to a Non-Academic Online Journal and a Blog about Viral Hepatitis
We recommend that if you prefer non-academic language and are not yet subscribers to this online magazine or the HepVoice blog about viral hepatitis, that you should consider it. Here are the links.
Elimination of Hepatitis C and the Imperative for Trauma-Informed Care
Anyone interested in eliminating hepatitis C should read this article, "In...
Anyone interested in eliminating hepatitis C should read this article, "In the eyes of Indigenous people in Canada: exposing the underlying colonial etiology of hepatitis C and the imperative for trauma-informed care," which provides an accessible pathway to approaching Indigenous health issues in culturally-safe, historic trauma-informed ways.
It is the best article we've seen about dealing with liver disease within Canada's aboriginal populations, and
Friday, April 27, 2018
News Recap:
Warnings:
Synthetic cannabinoids and Hepatitis A could be a fatal combination. On April 9, 2018, the Missouri Department of Health and Senior Services (DHSS) issued a news release – “Use of Synthetic Cannabinoids Linked to Severe Bleeding in the US,” informing the public about the national outbreak of bleeding illnesses among those consuming synthetic cannabinoids which appear to have been contaminated with a long-...
11 April 2018, Paris, France: Two independent studies have today reported that alcoholic liver disease has now replaced hepatitis C virus (HCV) infection as the leading cause of liver transplantation in the USA in patients without HCC. Non-alcoholic steatohepatitis (NASH) is also on the increase, now ranking second as a cause of liver transplantation due to chronic liver disease.
Chronic HCV infection has remained the leading indication for liver transpla...
Friday, April 6, 2018
News Recap:
HCV – Liver Cancer (HCC):
Liver Cancer on the Rise in Backdrop of Undiagnosed Hep C. Liver cancer, one of the greatest challenges to hepatologists today, will be in the spotlight at the upcoming International Liver Congress (ILC) 2018. It will become an even greater challenge in the near future, said Morris Sherman, PhD, from the University of Toronto, who is chair of the Canadian Liver Foundation.
Testing for he...
It is estimated 0.7 per cent of the UK population or around 441,000, have the virus which can cause deadly hepatitis-B-related liver disease.
It is highly contagious and mainly transmitted from infected mothers to their babies, through unprotected sex or contaminated needles.
Yet despite a test being available since the 1970s just a fifth of infected Britons have been diagnosed.
It is less common in the UK than other parts of the world, but people o
TORONTO, March 1, 2018 /CNW/ - An estimated eight million Canadians may be affected by liver disease, an illness that exhibits little to no symptoms, involves everyone from newborns to seniors, and is rarely tested by doctors during annual checkups.
Recent indicators gathered by the Canadian Liver Foundation (CLF) show that an increased prevalence of liver diseases including non-alcoholic fatty liver disease (NAFLD), chronic hepatitis B & C, and liver
Friday, February 16, 2018
News Recap:
HCV & Heart Disease:
Evolving Recognition of Chronic Hepatitis C Infection as a Modifiable Risk Factor for CVD. This article examines the evidence for clinical and subclinical cardiovascular diseases in chronic hepatitis c infection, as well as the effect of treatment on cardiovascular outcomes.
News from Around the World:
NZ: Thousands of Hepatitis C sufferers unaware a cure is within reach. A Hepatitis...
